Comparative efficacy, safety and durability of dolutegravir relative to common core agents in treatment-naïve patients infected with HIV-1: an update on a systematic review and network meta-analysis

BACKGROUND: The objective of this study was to assess the durability of response of dolutegravir (DTG) as an antiretroviral core agent by comparing its efficacy and safety with other recommended or commonly used core agents up to 96-weeks (W96). METHODS: A previously published systematic review was...

Descripción completa

Detalles Bibliográficos
Autores principales: Nickel, Katharina, Halfpenny, Nicholas J. A., Snedecor, Sonya J., Punekar, Yogesh Suresh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908737/
https://www.ncbi.nlm.nih.gov/pubmed/33637050
http://dx.doi.org/10.1186/s12879-021-05850-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908737/
https://www.ncbi.nlm.nih.gov/pubmed/33637050
http://dx.doi.org/10.1186/s12879-021-05850-0

Ejemplares similares